Mycophenolic Acid 180 mg/1 TABLET, DELAYED RELEASE
Accord Healthcare Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Mycophenolic acid is an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant. ( 1.1 ) Use in combination with cyclosporine and corticosteroids. ( 1.1 ) Limitations of Use: Mycophenolic acid delayed-release tablets and mycophenolate mofetil tablets and capsules should not be used interchangeably…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other Mycophenolic Acid NDC Codes
Wholesale and compliance resources
Order NDC 16729-0261-29 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).